<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">morpho</journal-id><journal-title-group><journal-title xml:lang="ru">Морфологические ведомости</journal-title><trans-title-group xml:lang="en"><trans-title>Morphological newsletter</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1812-3171</issn><issn pub-type="epub">2686-8741</issn><publisher><publisher-name>Private Medical University REAVIZ</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20340/mv-mn.2023.31(3).809</article-id><article-id custom-type="elpub" pub-id-type="custom">morpho-809</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>RESEARCH ARTICLES</subject></subj-group></article-categories><title-group><article-title>СТРУКТУРНАЯ ОРГАНИЗАЦИЯ АСТРОЦИТОВ ЦЕНТРАЛЬНОГО ЯДРА МИНДАЛЕВИДНОГО КОМПЛЕКСА КРЫС ЛИНИИ DAT-HET</article-title><trans-title-group xml:lang="en"><trans-title>THE STRUCTURAL ORGANIZATION OF ASTROCYTES OF THE AMYGDALA COMPLEX CENTRAL NUCLEUS OF THE DAT-HET LINE RATS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Давлетбаева</surname><given-names>Айгуль Рамилевна</given-names></name><name name-style="western" xml:lang="en"><surname>Davletbaeva</surname><given-names>Aigul' R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассистент кафедры физиологии и общей биологии</p></bio><bio xml:lang="en"><p>Assistant of the Department of Physiology and General Biology</p></bio><email xlink:type="simple">khabudinva@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Федорова</surname><given-names>Альбина Мубараковна</given-names></name><name name-style="western" xml:lang="en"><surname>Fedorova</surname><given-names>Al'bina M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доцент, кандидат биологических наук, доцент кафедры физиологии и общей биологии</p></bio><bio xml:lang="en"><p>Docent, Candidate of Biological Sciences, Associate Professor of the Department of Physiology and General Biology</p></bio><email xlink:type="simple">albinamfedorova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хисматуллина</surname><given-names>Зухра Рашидовна</given-names></name><name name-style="western" xml:lang="en"><surname>Khismatullina</surname><given-names>Zukhra R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор биологических наук, профессор, заведующая кафедрой  физиологии и общей биологии</p></bio><bio xml:lang="en"><p>Doctor of Biological Sciences, Professor, Head of the Department of Physiology and General Biology</p></bio><email xlink:type="simple">hismatullinazr@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Уфимский университет науки и технологий, Уфа</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ufa University of Science and Technology, Ufa</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>06</day><month>08</month><year>2023</year></pub-date><volume>31</volume><issue>3</issue><issue-title>МОРФОЛОГИЧЕСКИЕ ВЕДОМОСТИ - MORPHOLOGICAL NEWSLETTER 2023-31-4</issue-title><fpage>7</fpage><lpage>13</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Давлетбаева А.Р., Федорова А.М., Хисматуллина З.Р., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Давлетбаева А.Р., Федорова А.М., Хисматуллина З.Р.</copyright-holder><copyright-holder xml:lang="en">Davletbaeva A.R., Fedorova A.M., Khismatullina Z.R.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.morpholetter.com/jour/article/view/809">https://www.morpholetter.com/jour/article/view/809</self-uri><abstract><p>Центральное ядро миндалевидного комплекса является интегративным центром и основным каналом связи с остальным мозгом. Показано, что оно связано с важнейшими гипоталамическими и висцеральными центрами. Изучение морфологии его нейронов и их ответной реакции необходимо для понимания того, как эта структура регулирует различные аспекты поведения в норме и при психических расстройствах. Цель настоящего исследования состояла в изучении морфологической организации астроцитов центрального ядра миндалевидного комплекса крыс линии DAT-HET. Крысы линии DAT-HET являются гетерозиготами (HET) по нокауту гена белка - дофаминового транспортера (DAT), имеют ряд поведенческих особенностей, повышенную двигательную и исследовательскую активность и одновременно повышенную поведенческую тревожность. Исследование выполнено на лабораторных крысах-самцах двух линий: линии Wistar (n=8), линии DAT-HET (n=7) с массой тела от 200 г до 265 г в возрасте 5-6 месяцев. Центральное ядро миндалевидного комплекса было изучено на серии фронтальных срезов головного мозга крыс. В структуре центрального ядра миндалевидного комплекса у изучаемых групп животных хорошо дифференцируются медиальное и латеральное субъядра и объединяющая их промежуточная часть. Исследование морфометрических показателей площади субъядер центрального ядра миндалевидного комплекса показало, что у крыс линии Вистар площадь латерального субъядра достоверно выше при сравнении с аналогичным показателем крыс линии DAT-HET и эта разница составляет 29%. Сравнение степени экспрессии иммунопозитивных клеток к маркеру глиального фибриллярного кислого белка - белка промежуточных филаментов III типа, который экспрессируется многочисленными типами клеток центральной нервной системы, включая астроциты и эпендимальные клетки выявило, что у крыс линии DAT-HET площадь, занимаемая иммунопозитивными клетками также достоверно больше. Полученные результаты свидетельствуют о возможных процессах ремоделирования формы и размеров астроцитов, которые возникают в ответ на изменения дофаминергической трансмиссии, вызванные нокаутом соответствующего гена.</p></abstract><trans-abstract xml:lang="en"><p>The central nucleus of the amygdala complex is the integrative center and the main channel of communication with the rest of the brain. It has been shown that it is associated with the most important hypothalamic and visceral centers. Studying the morphology of its neurons and their response is necessary to understand how this structure regulates various aspects of behavior in normal conditions and in mental disorders. The purpose of this study was the morphological organization of astrocytes in the central nucleus of the amygdala complex in DAT-HET rats. DAT-HET rats are heterozygotes (HET) for knockout of the dopamine transporter (DAT) protein gene and have a number of behavioral characteristics, increased motor and exploratory activity, and at the same time increased behavioral anxiety. The study was carried out on male laboratory rats of two lines: Wistar line (n=8), DAT-HET line (n=7) with body weight from 200 g to 265 g at the age of 5-6 months. The central nucleus of the amygdala complex was studied in a series of frontal sections of the rat brain. In the structure of the central nucleus of the amygdala complex in the studied groups of animals, the medial and lateral sub-nuclei and the intermediate part that unites them are well differentiated. A study of morphometric indicators of the area of the sub-nuclei of the central nucleus of the amygdala complex showed that in Wistar rats the area of the lateral sub-nucleus is significantly higher when compared with the same indicator in DAT-HET rats, and this difference is 29%. Comparison of the degree of expression of immune-positive cells for the marker of glial fibrillary acidic protein - type III intermediate filament protein, which is expressed by numerous types of cells of the central nervous system, including astrocytes and ependymal cells, revealed that in DAT-HET rats the area occupied by immune-positive cells is also significantly larger. The results obtained indicate possible processes of remodeling the shape and size of astrocytes that occur in response to changes in dopaminergic transmission caused by knockout of the corresponding gene.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>миндалевидный комплекс</kwd><kwd>центральное ядро</kwd><kwd>астроциты</kwd><kwd>дофамин</kwd><kwd>крысы линии DAT-HET</kwd></kwd-group><kwd-group xml:lang="en"><kwd>amygdala complex</kwd><kwd>central nucleus</kwd><kwd>astrocytes</kwd><kwd>dopamine</kwd><kwd>DAT-HET rats</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Cardinal RN, Parkinson JA, Hall J, Everitt BJ. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev. 2002;26(3):321–352. DOI: 10.1016/s0149-7634(02)00007-6</mixed-citation><mixed-citation xml:lang="en">Cardinal RN, Parkinson JA, Hall J, Everitt BJ. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev. 2002;26(3):321–352. DOI: 10.1016/s0149-7634(02)00007-6</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmadeev AV, Kalimullina LB. Central'noe yadro mindalevidnogo kompleksa mozga: struktura, neyrohimiya, svyazi i funktsii. Uspekhi fiziologicheskikh nauk. 2020;51(3):69-86. DOI: 10.31857/S0301179820030030. In Russian</mixed-citation><mixed-citation xml:lang="en">Ahmadeev AV, Kalimullina LB. Central'noe yadro mindalevidnogo kompleksa mozga: struktura, neyrohimiya, svyazi i funktsii. Uspekhi fiziologicheskikh nauk. 2020;51(3):69-86. DOI: 10.31857/S0301179820030030. In Russian</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Morales L, Castro-Robles B, Abellán A, Desfilis E. A novel telencephalon-opto-hypothalamic morphogenetic domain coexpressing Foxg1 and Otp produces most of the glutamatergic neurons of the medial extended amygdala. J Comp Neurol. 2021;529:2418–2449. DOI: 10.1002/cne.25103</mixed-citation><mixed-citation xml:lang="en">Morales L, Castro-Robles B, Abellán A, Desfilis E. A novel telencephalon-opto-hypothalamic morphogenetic domain coexpressing Foxg1 and Otp produces most of the glutamatergic neurons of the medial extended amygdala. J Comp Neurol. 2021;529:2418–2449. DOI: 10.1002/cne.25103</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kolotilova OI, Korenyuk II, Khusainov DR, Cheretaev IV. Dofaminergicheskaya sistema mozga. Vestnik Bryanskogo gosudarstvennogo universiteta. 2014;(4):97-106. In Russian</mixed-citation><mixed-citation xml:lang="en">Kolotilova OI, Korenyuk II, Khusainov DR, Cheretaev IV. Dofaminergicheskaya sistema mozga. Vestnik Bryanskogo gosudarstvennogo universiteta. 2014;(4):97-106. In Russian</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Giros B, Caron MG. Molecular characterization of the dopamine transporter. Trends Pharmacol Sci. 1993;14(2):43-49. DOI: 10.1016/0165-6147(93)90029-j</mixed-citation><mixed-citation xml:lang="en">Giros B, Caron MG. Molecular characterization of the dopamine transporter. Trends Pharmacol Sci. 1993;14(2):43-49. DOI: 10.1016/0165-6147(93)90029-j</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Hyman SE. Addiction to cocaine and amphetamine. Neuron. 1996;16(5):901-904. DOI: 10.1016/s0896-6273(00)80111-7</mixed-citation><mixed-citation xml:lang="en">Hyman SE. Addiction to cocaine and amphetamine. Neuron. 1996;16(5):901-904. DOI: 10.1016/s0896-6273(00)80111-7</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mehler-Wex C, Riederer P, Gerlach M. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Neurotox res. 2006;10(3-4):167-179. DOI: 10.1007/BF03033354</mixed-citation><mixed-citation xml:lang="en">Mehler-Wex C, Riederer P, Gerlach M. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Neurotox res. 2006;10(3-4):167-179. DOI: 10.1007/BF03033354</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Doggrell SA. The therapeutic potential of dopamine modulators on the cardiovascular and renal systems. Expert Opin Investig Drugs. 2002;11(5):631-644. DOI: 10.1517/13543784.11.5.631</mixed-citation><mixed-citation xml:lang="en">Doggrell SA. The therapeutic potential of dopamine modulators on the cardiovascular and renal systems. Expert Opin Investig Drugs. 2002;11(5):631-644. DOI: 10.1517/13543784.11.5.631</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Wheeler MA, Clark IC, Tjon EC et al. MAFG-driven astrocytes promote CNS inflammation. Nature. 2020;578(7796):593-599. DOI: 10.1038/s41586-020-1999-0</mixed-citation><mixed-citation xml:lang="en">Wheeler MA, Clark IC, Tjon EC et al. MAFG-driven astrocytes promote CNS inflammation. Nature. 2020;578(7796):593-599. DOI: 10.1038/s41586-020-1999-0</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Linnerbauer M, Wheeler MA, Quintana FJ. Astrocyte crosstalk in CNS inflammation. Neuron. 2020;108(4):608-622. DOI: 10.1016/j.neuron.2020.08.012</mixed-citation><mixed-citation xml:lang="en">Linnerbauer M, Wheeler MA, Quintana FJ. Astrocyte crosstalk in CNS inflammation. Neuron. 2020;108(4):608-622. DOI: 10.1016/j.neuron.2020.08.012</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Wheeler MA, Quintana FJ. Regulation of astrocyte functions in multiple sclerosis. Cold Spring Harb Perspect Med. 2019;9(1):a029009. DOI: 10.1101/cshperspect.a029009</mixed-citation><mixed-citation xml:lang="en">Wheeler MA, Quintana FJ. Regulation of astrocyte functions in multiple sclerosis. Cold Spring Harb Perspect Med. 2019;9(1):a029009. DOI: 10.1101/cshperspect.a029009</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Habib N, McCabe C, Medina S, et al. Disease-associated astrocytes in Alzheimer's disease and aging. Nat Neurosci. 2020;23(6):701-706. DOI: 10.1038/s41593-020-0624-8</mixed-citation><mixed-citation xml:lang="en">Habib N, McCabe C, Medina S, et al. Disease-associated astrocytes in Alzheimer's disease and aging. Nat Neurosci. 2020;23(6):701-706. DOI: 10.1038/s41593-020-0624-8</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Mathys H, Davila-Velderrain J, Peng Z, et al. Single-cell transcriptomic analysis of Alzheimer's disease. Nature. 2019;570(7761):332-337. DOI: 10.1038/s41586-019-1195-2</mixed-citation><mixed-citation xml:lang="en">Mathys H, Davila-Velderrain J, Peng Z, et al. Single-cell transcriptomic analysis of Alzheimer's disease. Nature. 2019;570(7761):332-337. DOI: 10.1038/s41586-019-1195-2</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou Y, Song WM, Andhey PS, et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease. Nat Med. 2020;26(1):131-142. DOI: 10.1038/s41591-019-0695-9</mixed-citation><mixed-citation xml:lang="en">Zhou Y, Song WM, Andhey PS, et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease. Nat Med. 2020;26(1):131-142. DOI: 10.1038/s41591-019-0695-9</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Yun SP, Kam TI, Panicker N, et al. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease. Nat Med. 2018;24(7):931-938. DOI: 10.1038/s41591-018-0051-5</mixed-citation><mixed-citation xml:lang="en">Yun SP, Kam TI, Panicker N, et al. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease. Nat Med. 2018;24(7):931-938. DOI: 10.1038/s41591-018-0051-5</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Booth HDE, Hirst WD, Wade-Martins R. The role of astrocyte dysfunction in Parkinson's disease pathogenesis. Trends Neurosci. 2017;40(6):358-370. DOI: 10.1016/j.tins.2017.04.001</mixed-citation><mixed-citation xml:lang="en">Booth HDE, Hirst WD, Wade-Martins R. The role of astrocyte dysfunction in Parkinson's disease pathogenesis. Trends Neurosci. 2017;40(6):358-370. DOI: 10.1016/j.tins.2017.04.001</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Yu X, Taylor AMW, Nagai J, et al. Reducing astrocyte calcium signaling in vivo alters striatal microcircuits and causes repetitive behavior. Neuron. 2018;99(6):1170-1187.e9. DOI: 10.1016/j.neuron.2018.08.015</mixed-citation><mixed-citation xml:lang="en">Yu X, Taylor AMW, Nagai J, et al. Reducing astrocyte calcium signaling in vivo alters striatal microcircuits and causes repetitive behavior. Neuron. 2018;99(6):1170-1187.e9. DOI: 10.1016/j.neuron.2018.08.015</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Nagai J, Yu X, Papouin T, et al. Behaviorally consequential astrocytic regulation of neural circuits. Neuron. 2021;109(4):576-596. DOI: 10.1016/j.neuron.2020.12.008</mixed-citation><mixed-citation xml:lang="en">Nagai J, Yu X, Papouin T, et al. Behaviorally consequential astrocytic regulation of neural circuits. Neuron. 2021;109(4):576-596. DOI: 10.1016/j.neuron.2020.12.008</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Perez-Alvarez A, Navarrete M, Covelo A, et al. Structural and functional plasticity of astrocyte processes and dendritic spine interactions. J Neurosci. 2014;34(38):12738-12744. DOI: 10.1523/JNEUROSCI.2401-14.2014</mixed-citation><mixed-citation xml:lang="en">Perez-Alvarez A, Navarrete M, Covelo A, et al. Structural and functional plasticity of astrocyte processes and dendritic spine interactions. J Neurosci. 2014;34(38):12738-12744. DOI: 10.1523/JNEUROSCI.2401-14.2014</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Molofsky AV, Krencik R, Ullian EM, et al. Astrocytes and disease: a neurodevelopmental perspective. Genes Dev. 2012;26(9):891-907. DOI: 10.1101/gad.188326.112</mixed-citation><mixed-citation xml:lang="en">Molofsky AV, Krencik R, Ullian EM, et al. Astrocytes and disease: a neurodevelopmental perspective. Genes Dev. 2012;26(9):891-907. DOI: 10.1101/gad.188326.112</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Burda JE, Sofroniew MV. Reactive gliosis and the multicellular response to CNS damage and disease. Neuron. 2014;81(2):229-248. DOI: 10.1016/j.neuron.2013.12.034</mixed-citation><mixed-citation xml:lang="en">Burda JE, Sofroniew MV. Reactive gliosis and the multicellular response to CNS damage and disease. Neuron. 2014;81(2):229-248. DOI: 10.1016/j.neuron.2013.12.034</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Pekny M, Pekna M. Astrocyte reactivity and reactive astrogliosis: costs and benefits. Physiol Rev. 2014;94(4):1077-1098. DOI: 10.1152/physrev.00041.2013</mixed-citation><mixed-citation xml:lang="en">Pekny M, Pekna M. Astrocyte reactivity and reactive astrogliosis: costs and benefits. Physiol Rev. 2014;94(4):1077-1098. DOI: 10.1152/physrev.00041.2013</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Sydney: Academic, 1998. 300 рp</mixed-citation><mixed-citation xml:lang="en">Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Sydney: Academic, 1998. 300 рp</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson MA, Ao Y, Sofroniew MV. Heterogeneity of reactive astrocytes. Neurosci Lett. 2014;565:23-29. DOI: 10.1016/j.neulet.2013.12.030</mixed-citation><mixed-citation xml:lang="en">Anderson MA, Ao Y, Sofroniew MV. Heterogeneity of reactive astrocytes. Neurosci Lett. 2014;565:23-29. DOI: 10.1016/j.neulet.2013.12.030</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y, Yin A, Sun X, et al. Deficiency of tumor suppressor NDRG2 leads to attention deficit and hyperactive behavior. J Clin Invest. 2017;127(12):4270-4284. DOI: 10.1172/JCI94455</mixed-citation><mixed-citation xml:lang="en">Li Y, Yin A, Sun X, et al. Deficiency of tumor suppressor NDRG2 leads to attention deficit and hyperactive behavior. J Clin Invest. 2017;127(12):4270-4284. DOI: 10.1172/JCI94455</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Dong XX, Wang Y, Qin ZH. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin. 2009; 30(4):379-387. DOI: 10.1038/aps.2009.24</mixed-citation><mixed-citation xml:lang="en">Dong XX, Wang Y, Qin ZH. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin. 2009; 30(4):379-387. DOI: 10.1038/aps.2009.24</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Meldrum BS. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr. 2000;130(4S Suppl):1007-1015. DOI: 10.1093/jn/130.4.1007S</mixed-citation><mixed-citation xml:lang="en">Meldrum BS. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr. 2000;130(4S Suppl):1007-1015. DOI: 10.1093/jn/130.4.1007S</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson CM, Swanson RA. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia. 2000;32(1):1-14</mixed-citation><mixed-citation xml:lang="en">Anderson CM, Swanson RA. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia. 2000;32(1):1-14</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Hefendehl JK, LeDue J, Ko RW, et al. Mapping synaptic glutamate transporter dysfunction in vivo to regions surrounding Aβ plaques by iGluSnFR two-photon imaging. Nat Commun. 2016;7:13441. DOI: 10.1038/ncomms13441</mixed-citation><mixed-citation xml:lang="en">Hefendehl JK, LeDue J, Ko RW, et al. Mapping synaptic glutamate transporter dysfunction in vivo to regions surrounding Aβ plaques by iGluSnFR two-photon imaging. Nat Commun. 2016;7:13441. DOI: 10.1038/ncomms13441</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Chung EK, Chen LW, Chan YS, Yung KK. Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats. J Comp Neurol. 2008;511(4):421-437. DOI: 10.1002/cne.21852</mixed-citation><mixed-citation xml:lang="en">Chung EK, Chen LW, Chan YS, Yung KK. Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats. J Comp Neurol. 2008;511(4):421-437. DOI: 10.1002/cne.21852</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Liang Z, Valla J, Sefidvash-Hockley S, et al. Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients. J Neurochem. 2002;80(5):807-814. DOI: 10.1046/j.0022-3042.2002.00779.x</mixed-citation><mixed-citation xml:lang="en">Liang Z, Valla J, Sefidvash-Hockley S, et al. Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients. J Neurochem. 2002;80(5):807-814. DOI: 10.1046/j.0022-3042.2002.00779.x</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J, Liu M, Hou W, et al. N-myc Downstream-Regulated Gene 2 (Ndrg2): A Critical Mediator of Estrogen-Induced Neuroprotection Against Cerebral Ischemic Injury. Mol Neurobiol. 2022;59(8):4793-4804. DOI: 10.1007/s12035-022-02877-5</mixed-citation><mixed-citation xml:lang="en">Wang J, Liu M, Hou W, et al. N-myc Downstream-Regulated Gene 2 (Ndrg2): A Critical Mediator of Estrogen-Induced Neuroprotection Against Cerebral Ischemic Injury. Mol Neurobiol. 2022;59(8):4793-4804. DOI: 10.1007/s12035-022-02877-5</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Safieh-Garabedian B, Mayasi Y, Saadé NE. Targeting neuroinflammation for therapeutic intervention in neurodegenerative pathologies: a role for the peptide analogue of thymulin (PAT). Expert Opin Ther Targets. 2012;16(11):1065-1073. DOI: 10.1517/14728222.2012.714773</mixed-citation><mixed-citation xml:lang="en">Safieh-Garabedian B, Mayasi Y, Saadé NE. Targeting neuroinflammation for therapeutic intervention in neurodegenerative pathologies: a role for the peptide analogue of thymulin (PAT). Expert Opin Ther Targets. 2012;16(11):1065-1073. DOI: 10.1517/14728222.2012.714773</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Colombo E, Farina C. Astrocytes: Key Regulators of Neuroinflammation. Trends Immunol. 2016;37(9):608-620. DOI: 10.1016/j.it.2016.06.006</mixed-citation><mixed-citation xml:lang="en">Colombo E, Farina C. Astrocytes: Key Regulators of Neuroinflammation. Trends Immunol. 2016;37(9):608-620. DOI: 10.1016/j.it.2016.06.006</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
